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1.Pharmaceutical:
• finished dosage forms and includes both 
prescription and non-prescription medicinal 
products for human use which registered 
with the Drug Control  Authority(DCA), 
Ministry of Health Malaysia.
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2.Halal Pharmaceutical: Definition
Pharmaceutical products that contain ingredient permitted 
under the Shariah.
1. Do not contain any parts of animals that are not-
halal/does not slaughtered according to Shariah;
2. Do not contain any human parts/derivatives;
3. Do not contain najis
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4. Safe for consumption/non-poisonous/non-
intoxicating/hazardous to health
5. Processed using equipments free from najis;
6. Total separation from non-halal items/najis (preparation, 
handling,storage,distribution)
Source: MS 2424:2010 (P)
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Total Compliance to MS 2424:2010 & 
Existing Regulations…
5
Halal Certificates from Islamic Development 
Department of Malaysia (JAKIM)
 Halal Edible & Pharmaceutical Gelatin  Halal Empty Hard Gelatin Capsule 
3.Law & Consumer protection
• Malaysia puts country’s healthcare industry as one of its
top priorities, and continually implements new policies to
ensure that the medical sector continue progressing and
at the same time to ensure that its people receive the best
medical treatment available.
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Consumer protection…
In Malaysia, Pharmaceuticals are regulated by the Drug 
Control Authority (DCA);
under the Control of Drugs and Cosmetics Regulations 
1984;
The main responsibility of the DCA is to ensure the safety,
quality and efficacy of pharmaceuticals in Malaysia
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Consumer Protection…
• Any drug in a pharmaceutical dosage form, intended to be 
used, or capable or purported or claimed to be capable of 
being used on humans or any animals, whether internally 
or externally, for a medicinal purpose is required to be 
registered with the DCA.
• This includes products which alleviate, treat or cure 
diseases, products that diagnose a disease, anesthetics, 
and products that maintain, modify, prevent, restore or 
interfere with normal physiological functions.
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Exemption…
• The regulation does not apply to diagnostic agents and 
test kits for laboratory use; 
• non-medicated medical and contraceptive devices; 
• non-medicated bandages and surgical dressings; and
• instruments, apparatus, syringes, needles, sutures and 
catheters.
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Imported Product and Consumer 
Protection…
• Due to the concern with counterfeit and unregistered 
pharmaceuticals in Malaysia, the MOH has issued a 
Directive on the Use of the Hologram Security Device
( “the Directive”).
 The Directive requires all pharmaceutical products, 
including health supplements, traditional products and 
over-the-counter (OTC) external personal care products 
to bear a hologram security label known as MeditagTM.
The hologram will have a unique serial number, which 
verifies that the product has been registered with the DCA 
and the hologram can be traced to the manufacturer or 
importer of the product.
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Implementation: 
• This requirement was implemented in two phases. 
1st January 2005 where all non-parenteral products have 
been required to be labeled with the hologram label;
all injectable pharmaceuticals are required to be labeled 
with the hologram label since Phase 2 began on 1st July 
2005.
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Exemption…
• The Directive excludes temperature-sensitive products 
that require cold chain maintenance, such as vaccines 
and biologicals and cosmetic products from having the 
hologram labeling.
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Consumer protection…
The hologram should be placed on the front panel of the 
product label on the outer packaging of the product;
Each unit of sale requires a hologram; 
customer should be able to see the hologram without 
opening the box or the container of the product.
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Legal Consequences… 
• The Directive puts the burden on the manufacturer or the
re-packer in the case of products that are imported to
Malaysia and packed locally or the importer in ensuring
that the hologram label is affixed to the products before
they are being marketed in Malaysia.
• However, the labels may also be sent to the overseas
manufacturer of the product, affixed overseas, and then
imported back to Malaysia.
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Legal Consequences…
• companies who’s products are still on the shelves without 
an affixed hologram will not be required to conduct a 
recall. It is simply up to the customers to decide whether 
they feel comfortable purchasing products without a 
hologram. (non-retrospective)
• However, if a manufacturer or importer does not show any 
attempt to meet the hologram labeling requirements, the 
MOH can suspend the product registration until the 
manufacturer or importer complies with the new 
regulation.
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Legal Consequences…
• With the implementation of the “Directive”, selling 
products which are not affixed with the Meditag™ is an 
offence and first time individual offenders could face a fine 
of RM25000 (approximately USD6600) and/or 
imprisonment of three years and a fine of RM50000 
(approximately USD13200) and/or imprisonment of five 
years for a subsequent offence.
• If the offence was committed by a corporate entity, the 
entity can be slapped with a fine of RM50,000 
(approximately USD13200) for first offence and 
RM100,000 (approximately USD26400) for a subsequent 
offence. 
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Ultimate Goal…
• with the “Directive”, Malaysians are 
guaranteed to receive genuine patented 
drugs and their generics and protected 
from imitation drugs which can be harmful.
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4. SAFETY: labelling requirements in respect of pharmaceutical 
products for the purpose of registration
• General Labelling Requirements
• 1. Name of the product.
• 2. Name and quantity of each active ingredient.
• 3. Name and address of the manufacturer.
• 4. Hong Kong registration number of the product.
• 5. Batch Number.
• 6. Expiry date.
• 7. Specific storage conditions, if any.
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Labelling requirements…
• Additional Labelling Requirements for Sterile 
Products
• 1. Name and quantity of preservatives, if any.
• 2. Batch number and expiry date (on sales pack and 
on each ampoule/vial).
•
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Labelling requirements…
• Additional Labelling Requirements for Certain Classes of Products
• 1. For embrocations, liniments, lotions, liquid antiseptics or other liquid 
medicines for external application -
•
• “For external use only.  只供外用。”
• 2. For veterinary products -
• “For animal treatment only.  只限醫治禽畜用。”
• 3. For mouthwashes -
• “Not to be swallowed.  不可吞服。”
• 4. For eye-drops -
• “Not to be used one month after opening.  開蓋一個月後不可使用。”
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Labelling requirements…
• Additional Labelling Requirements for Non-poisons 
and Part II Poisons
1.Dosage, route and frequency of administration in both 
English and Chinese. 
(For injectable products, words such as “To be used only 
as directed by a medical practitioner 請遵照醫生指示使用
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Labelling/warning requirements…
For medicines containing Salicylamide -
• The following is required on the label and/or package 
insert -
• “Keep out of reach of children.  This medicine should not 
be given to children under 16 except on medical advice.  
避免兒童誤取。非經醫生指示，十六歲以下兒童不可服用
。”
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For medicines containing Phenylpropanolamine -
• The maximum daily dose should not exceed 100mg and on the label or in 
the package insert :-
• (i)“If you are under the care of your doctor or receiving continual prescribed 
medication or are pregnant then consult your doctor.
假如你是在醫生的照料下或長期服用藥物或懷孕，請徵詢醫生意見。”
•
(ii)"Patients with high blood pressure, hyperthyroidism, heart disease or 
who are receiving monoamine oxidase inhibitors should not take the 
product. 患有高血壓、甲狀腺素高、心臟病或正接受單氨基酸抑制劑治療的病
人不可服用此葯。"
(iii)"The product may aggravate conditions such as diabetes, glaucoma, or 
prostatic enlargement.此葯可使糖尿病、青光眼和前列腺肥大等病症的病情
轉壞。“
(iv) "The product should not be used as appetite suppressant.此葯不可作
食慾抑制劑使用。“
DEPARTMENT OF HEALTH
PHARMACEUTICAL SERVICE
PHARMACEUTICALS REGISTRATION SECTION
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ASEAN COUNTRIES Labelling
Requirements
• 1. PHILIPPINES
• 2. INDONESIA
• 3. THAILAND
• 4. SINGAPORE
• 5. MALAYSIA
• 6.VIETNAM
• 7. LAOS
• 8.CAMBODIA
• 9. BRUNEI DARUSSALAM
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Example:
LABELING REQUIREMENTS (COUNTRY SPECIFIC) – THAILAND
• According to Drug Acts, these words have to be written in 
Thai;
Dangerous drug, 
Specially Controlled drug, 
For external use,
Common Household remedy, 
Topical use, 
Expiry date.
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5.JURISDICTION?
“Food” or “Food Supplement”?
 Food?
Food Act (Food Regulations 
1985)1983
 Food Safety and Quality 
Division(MOH)
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Food Supplement?(which are treated as 
health supplement)
“food” or “pharmaceutical”?
• Committee for the Classification of Food-
Drug Interface Products has developed a 
classification system to determine whether 
the launch of a product in question is to be 
regulated by the Drug Control Authority 
(“DCA”) of the National Pharmaceutical 
Control Bureau or the Food Quality Division 
(“FQD”). 
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• If a product contains 80% or more of food-based 
ingredients, singly or in combination, with equal to or less 
than 20% of biologically active ingredients (such as 
vitamins, minerals, amino acids), the product is 
considered as a food product and shall be regulated by 
the Food Safety and Quality Division
• The governing law will be the Food Act (Food Regulations 
1985) 1983 
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• However, 
If a product contains less than 80% of food-based 
ingredients, with more than 20% of the active ingredients, 
the product is considered as pharmaceutical product and 
shall be regulated by the DCA.
 A product which contains solely natural ingredients that 
are not traditionally used as food and possesses medicinal 
value such as alfalfa, spirulina, royal jelly, noni juice, 
rooibos tea, pegaga tablet and other herbal products, is 
regulated by the DCA. 
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labeling requirements specifically provided for health 
supplement products:
e.g. Obligatory information, warnings or statements 
Registration Number. For e.g. MAL 12345678HN 
 Batch Number 
 Manufacturing Date 
 Expiry Date 
 Route of administration / dose / use instruction 
 Dosage form 
 Pack size 
 Storage condition 
 The words “Keep out of reach of children” or words bearing 
similar meaning in both Bahasa Malaysia (national language of 
Malaysia) and English 
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• Ingredients 
Nutrient function claims of the individual vitamins or 
minerals are allowed. For e.g. Vitamin A helps to maintain 
growth, vision and tissue development etc. 
Name and strength of active substances 
Name and content of preservative (where present) 
 Name and content of alcohol (where present) 
 Source of ingredients (active, excipient, and/or capsule 
shell) – derived from animal origin 
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6.FATWA and Drug Administration
1. Hukum Penggunaan Vaksin Meningitis Menveo
• Muzakarah Jawatankuasa Fatwa Majlis Kebangsaan Bagi Hal Ehwal Ugama Islam
Malaysia Kali Ke-94 yang bersidang pada 20 - 22 April 2011 telah membincangkan
Hukum Penggunaan Vaksin Meningitis Menveo. Muzakarah telah memutuskan seperti
berikut:
• Setelah mendengar taklimat dan penjelasan daripada Biro Pengawalan Farmaseutikal
Kebangsaan (BPFK) dan meneliti keterangan, hujah-hujah serta pandangan yang
dikemukakan, Muzakarah mengambil perhatian bahawa proses penghasilan Vaksin
Menveo keluaran Syarikat Novartis Vaccines adalah sama sepertimana penghasilan
Vaksin Mencevax keluaran Syarikat Glaxo Smith Kline (GSK).
• Sehubungan itu, Muzakarah bersetuju memutuskan bahawa pada dasarnya hukum
penggunaan vaksin Menveo adalah harus atas dasar dharurah sama seperti vaksin
Mencevax yang telah diputuskan pada Muzakarah kali ke-53 bertarikh 27 November
2002 kerana sehingga kini masih belum ada mana-mana vaksin meningococcal
meningitis yang dihasilkan 100% halal dan suci daripada awal hingga akhir proses
penghasilannya.
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• Walaubagaimanapun untuk maslahah umat Islam, 
Muzakarah berpandangan di antara kedua-dua vaksin ini, 
keutamaan adalah kepada vaksin Mencevex yang telah
digunakan sekian lama dan telah terjamin dari segi
keberkesanan dan keselamatan kepada pengguna. 
Manakala vaksin Menveo masih baru di pasaran dan
pemonitoran kesan jangka panjang masih berterusan.
• Muzakarah juga berpandangan bahawa Sijil Halal tidak
wajar diberikan kepada vaksin Menveo kerana
penentuan harus adalah atas dasar dharurah dan proses 
penghasilannya tidak mematuhi piawaian pensijilan halal 
Malaysia.
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2.Meningococcal Meningitis Vaccination for 
Muslims
Decision:
The 53rd Muzakarah (Conference) of the Fatwa 
Committee of the National Council for Islamic 
Religious Affairs Malaysia held on 27th November 
2002 has discussed Meningococcal Meningitis 
vaccination for Muslims:
The Committee has decided that meningococcal 
meningitis mencevax vaccine extracted from cow 
sources is permissible;
 However, meningococcal meningitis monumune
vaccine that contains pig sources is forbidden.
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3. The Ruling of Botulinum Toxin Type A (BTA) 
Injection
Decision:
• The 73rd Muzakarah (Conference) of the Fatwa Committee of the National Council for 
Islamic Religious Affairs Malaysia held on 4th -6th April 2006 has discussed the ruling 
on botulinum toxin Type A (BTA) injection. The Committee has decided that:
• 1. After conducting careful examination on international and local research together 
with evidences brought by fatawa committee in some Muslim countries, it is 
concluded that botulinum toxin Type A or commercially known as botox does contain 
doubtful substances, najis (impure) and it is forbidden. Amongst the doubtful 
substances are pig extracts.
• 2. Botulinum toxin Type A injection or its commercial name botox can cause long and 
short term negative side effects to the users and it can be manipulated for scam.
•
3. On the bases of the statement above, the committee has concluded that the 
botulinum toxin Type A injection or its trade name, botox is forbidden;
• 4. However, the botulinum toxin Type A injection is permissible for medical 
purposes, on the condition that it is used for darura case (emergency), 
urgent need and conducted by a certified specialist. (Necessity/Pressing 
need)
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4.The Ruling on Using Biothrax Vaccine and 
Rotateq Vaccine that Used Pig Sources in its 
Production Process
• Decision:
• The 81st Muzakarah (Conference) of the Fatwa Committee 
National Council of Islamic Religious Affairs Malaysia held on 
31st March 2006 has discussed the ruling of using biothrax
vaccine and rotateq vaccine that used pig sources in its 
production process. The Committee has decided that the usage 
of Biothrax vaccine and RotaTeg are not permitted because:
• 1. No urgent need at the moment
• 2. There are alternative substances or medicines besides using 
pig sources in the production of the said vaccines
3. There is no concrete proof stating that people in the country 
are in dire need of such vaccine.
36
5. The Rulling on Using Human Papilloma Virus Vaccine 
(HPV)
• Muzakarah Jawatankuasa Fatwa Majlis Kebangsaan Bagi Hal Ehwal Ugama Islam 
Malaysia Kali Ke-92 yang bersidang pada 15 - 17 Disember 2010 telah
membincangkan Hukum Pengambilan Vaksin Human Papilloma Virus (HPV). 
Muzakarah telah membuat keputusan seperti berikut:
• Setelah mendengar taklimat daripada pihak Biro Pengawalan Farmaseutikal
Kebangsaan serta pandangan dan hujah-hujah yang dikemukakan, Muzakarah
berpandangan bahawa Islam menggesa umatnya supaya menjaga kesihatan kerana
penjagaan kesihatan seseorang individu akan menentukan tahap dan mutu kesihatan
masyarakat secara umumya. Pemberian vaksin merupakan jalan pencegahan awal
yang diambil oleh pihak Kerajaan dalam usaha mengelakkan penyebaran virus di 
kalangan wanita.
• Sehubungan itu, Muzakarah bersetuju memutuskan bahawa
pengambilan Vaksin Human Papilloma Virus (HPV) yang telah
dipastikan tiada unsur meragukan dalam kandungannya dan
tidak mendatangkan kemudharatan adalah diharuskan bagi
mencegah penyakit kanser pangkal rahim (servik) di kalangan
wanita.
• Muzakarah juga memutuskan bahawa pemvaksinan ini hendaklah tidak mengandungi
unsur-unsur eksploitasi terhadap pengguna atau digunakan untuk tujuan yang 
bercanggah dengan syarak.
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6.The Ruling on Using Ink for Cancer Treatment
• Decision:
• The 90th Muzakarah (Conference) of the Fatwa Committee National 
Council of Islamic Religious Affairs Malaysia held on 1st March 2010 
has discussed the ruling on using ink for cancer treatment. The 
Committee has decided that cancer treatment using Holbein drawing 
ink which is najis free is permissible and the patient can take the 
ablution as usual because the ink is only inserted underneath the 
skin.
• Penggunaan tandaan berdakwat untuk pesakit kanser ini
adalah berbeza daripada tatoo yang diharamkan oleh
Islam kerana tatoo dicacah ke dalam lapisan kulit dan ia
kekal selama-lamanya, manakala tandaan berdakwat ini
hanya dicucuk dengan menggunakan jarum kurang dari
1mm .
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7.Ruling on Using Clexane and Fraxiparine Medicines
• Decision:
• The 87th Muzakarah (Conference) of the Fatwa Committee National Council of Islamic 
Religious Affairs Malaysia held on 23rd-25th June 2009 has discussed the ruling on using 
clexane and fraxiparine medicines. The Committee has decided that:
• Islam prohibits using medicine derived from unlawful sources as a cure, except in a situation 
where there is no other lawful sources and the amount used according to the prescribed 
dosage only. The haram based medicine is only permitted to be used limitedly. The 
permissibility (of using haram based medicine) is annulled when the halal alternative is 
found.
• Thus, as regards to clexane and fraxiparine that are urgently 
needed by patients who are in critical condition to prevent sudden 
clotting of the blood, the Committee has decided that the 
medicines are forbidden. It is due to the availability of alternative 
medicine namely arixtra that is produced from lawful sources 
which has the same function and efficiency as clexane and 
fraxiparine (MAL 20034441A).
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8.Rubella Immunization
Decision:
The 21st Muzakarah (Conference) of the Fatwa 
Committee of the National Council for Islamic Religious 
Affairs Malaysia held on 12th September 1988 has 
discussed rubella immunization. The Committee has 
decided that the rubella vaccine provided by Malaysian 
Ministry of Health is not najis (ritually impure) and the 
injection is permitted to prevent rubella
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9.The View of Islam Regarding Measles, Tuberculosis, Diphtheria, 
Tetanus and Polio Immunizations
• Decision:
• The 24th Muzakarah (Conference) of the Fatwa 
Committee of the National Council for Islamic Religious 
Affairs Malaysia held on 5th -6th June 1989 has 
discussed the view of Islam regarding measles, 
tuberculosis, diphtheria, tetanus and polio immunizations. 
The Committee has decided that such immunizations are 
permissible in Islam.
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10.Hepatitis-B Immunization
• The 22nd Muzakarah (Conference) of the Fatwa 
Committee of the National Council for Islamic Religious 
Affairs Malaysia held on 24th November 1988 has 
discussed Hepatitis-B immunization. The Committee 
has decided that the vaccine of Hepatitis B 
extracted from yeast is not najis (ritually impure) 
and permitted to be used due to the fact that 
yeast is (ritually) pure.
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11. Use of Gelatin in Medicine
• The 8th Muzakarah (Conference) of the Fatwa Committee 
of the National Council for Islamic Religious Affairs 
Malaysia held on 24th -25th September 1984 has 
discussed gelatin in medicine. The Committee decided 
that gelatine in medicine is permissible because of 
necessity (darura). If there is any other alternative 
substance that can prevent medicine from easily 
deteriorating, hence the gelatin is no longer permitted.
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12. Use of Alcohol in Medicine
Decision:
 The 7th Muzakarah (Conference) of the Fatwa Committee of the National Council for Islamic 
Religious Affairs Malaysia held on 11th -12th April 1984 has discussed alcohol from Islamic 
point of view. The Committee has decided that:
 All liquor contains alcohol, but not all alcohol is liquor. Alcohol produced from liquor process 
is regarded as najis (ritually impure) but not alcohol produced from other than liquor process. 
Both types however are prohibited to be consumed.
 Soft drink produced in the same way of liquor production and contains either little amount of 
alcohol or the alcohol has been distilled is prohibited to be consumed

Soft drink produced not to become liquor or intoxicants item and produced not in the same 
process of liquor is lawful
 Tapai (fermented rice) is lawful to be eaten
 Alcohol produced as by product in food process is not najis and can be consumed
Medicines and fragrances containing alcohol are permissible
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13.Injection of Highly Purified Insulin Derived From Pig
Decision:
The 6th Muzakarah (Conference) of the Fatwa Committee 
of the National Council for Islamic Religious Affairs 
Malaysia held on 10th October 1983 has discussed 
injection of Highly purified insulin derived from pig. The 
Committee has decided that injecting highly 
purified insulin derived from najis mughallaza
(grave impure item that is pig) as medication for 
diabetics is permissible on the basis of 
emergency (Darurah). The ruling is applicable to 
the person who administers the injection.
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Dharurah/Necessity?
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2.PROPERTY
3.RELIGION
4.LIENAGE
5.MIND
1.LIFE
Objectives of 
Shariah
7.FATWA and Its Relevancy 
Peruntukan Mengenai Fatwa Dalam Undang-Undang
Di dalam Akta Pentadbiran Undang-Undang
Islam (Wilayah-Wilayah Persekutuan) 1993 [Akta
505], peruntukan mengenai fatwa dijelaskan di 
bawah Seksyen 34 iaitu:
 Maksud Fatwa iaitu pendapat atas apa-apa persoalan yang belum diselesaikan atau
yang menimbulkan pertikaian mengenai atau berhubung dengan Hukum Syarak;
Mengenai bila sesuatu fatwa itu boleh dibuat, iaitu apabila diperintahkan oleh
Yang di-Pertuan Agong, atau atas permintaan orang ramai melalui surat yang 
dihantar kepada Mufti, atau dibuat atas kehendak Mufti itu sendiri;
Sesuatu pernyataan yang dibuat oleh Mufti hanya boleh diambil sebagai fatwa 
jika pernyataan itu disiarkan dalam warta berhubung dengan Hukum Syarak;
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Sesuatu fatwa yang telah disiarkan dalam warta
(gazette) hendaklah dipatuhi oleh semua umat Islam 
yang berada di negeri itu, kecuali amalan peribadi yang 
dibenarkan mengikut Hukum Syarak; dan
Fatwa yang diwartakan merupakan sebahagian daripada
undang-undang yang perlu diikuti oleh semua Mahkamah
Syariah bagi negeri itu (binding)
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